Webinar with Dr Brennan Kahan, lecturer in medical statistics and the pragmatic clinical trials unit, Queen Mary University of London.
Over the past six years Dr Kahan had led research in the design and analysis of re-randomisation trials. Re-randomisation trials involve re-enrolling and re-randomising patients each time they experience a new treatment episode. This design has been used in areas such as asthma exacerbations (with re-enrollment for each new exacerbation), influenza vaccines (with re-enrollment for each new influenza season), and complications from cirrhosis (with re-enrolment for each new admission to hospital). Re-randomisation offers the potential to increase recruitment compared to parallel group trials, and provide more relevant estimates of treatment effectiveness.
Date/time: Nov 12, 2019 12:00 PM in Universal Time UTC